A new Mount Sinai study published in the Journal of the National Cancer Institute on September 10, 2024, has found that ...

For patients with limited-stage small cell lung cancer, adjuvant therapy with durvalumab leads to significantly longer ...

The toxicity of lung cancer treatment has traditionally been discussed in terms of physical symptoms, but there is a growing focus on financial toxicity, time toxicity, and other effects on well-being ...

Researchers have unveiled a potential paradigm shift in treatment strategies that could significantly improve patients' ...

There’s a new cancer-fighting tool at McLaren Greater Lansing Hospital that is now allowing doctors to diagnose lung cancer earlier and more accurately. Dr. Salah Aboubakr, the first to use this new ...

It's not only due to smoking, as this survivor's story might help demonstrate—says one expert doctor: "All you need to be at ...

Johnson & Johnson (JNJ) announced that the U.S. Food and Drug Administration approved RYBREVANT (amivantamab-vmjw) in combination ...

Gene mutations associated with non-small cell lung cancer include EGFR, HER2, and more. Lung cancer mutations can determine your options for testing and treatment. Genes are the instructions that ...

Sep. 12, 2024 — Researchers examined the impact of obesity in relation to treatment and mortality from data on over 500,000 lung cancer patients. This study suggests that immunotherapy may not ...

A new report shows rapid development of new cancer treatment and detection is helping people live more. But more people are ...

When lung cancer spreads beyond the lungs, it usually first affects nearby lymph nodes. But doctors don’t usually consider lung cancer to be “metastatic” until it has spread to more distant ...

This vaccine aims to treat non-small cell lung cancer (NSCLC), the most prevalent form of lung cancer. The phase 1 trial for BNT116 is underway at 34 sites across seven countries, including the UK ...